View all Oncology Briefing CME

Share a PER® activity with your colleagues or friends. Connect with the PER® social network.

Accreditation/ Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


PER Pulse™ Recap
A PER Pulse™ Recap summarizes data presented at the 2014 Annual Meeting of the American Association for Cancer Research on current advances in hormone receptor–positive breast cancer (HR+ BC) and current investigational approaches in hormone receptor–positive breast cancer (HR+ BC) that are in late-stage clinical development.

Commercial Supporter

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Oncology Briefing: Advances in Estrogen Receptor-Positive Breast Cancer

Release Date: August 1, 2014 Expiration Date: August 1, 2015
Media: Internet-based

Activity Overview

Oncology Briefing is an online monograph-style publication that will feature a review of data in breast cancer from recent international oncology meetings and peer-reviewed publications, highlighting practice-changing clinical trial results, safety and efficacy information about novel therapies, ongoing clinical trials testing novel therapies, and risk stratification of patients. Commentary by a leading expert in breast cancer, key take-home points, and pearls for practice will place the content into perspective. Sidebars and tables will provide supporting evidence.

Instructions for This Activity & Receiving Credit

  • Once you begin the activity, please answer demographic questions. This will allow you to proceed to the activity.
  • This activity contains an interactive question(s). You may move forward through the activity; however, you may not go back to change answers or review content until you finish the activity.
  • At the end of the activity, an "educational content" link will be available for users to download content in PDF format for your reference.
  • If you close the Web browser after you complete the activity, the "educational content" link will disappear and you will need to review the activity in its entirety to once again access the link to the "educational content.".
  • In order to receive a CME certificate, participants must complete the activity.
  • Click on the "Posttest, Evaluation, and Request for Credit" link at the end of the activity. Complete the posttest and pass with a score of 70% or higher, complete the evaluation, and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.


Target Audience

This online activity is directed toward medical oncologists, fellows, and other HCPs involved in the treatment and management of patients with breast cancer.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:
  • Incorporate new data on the use of systemic therapies for breast cancer (including endocrine, cytotoxic, targeted, and bone-modifying agents) into individualized treatment plans for patients, as appropriate, based upon an evaluation of efficacy and safety, as well as patient characteristics and tumor subtypes.
  • Evaluate emerging clinical data regarding new agents and evolving strategies for the treatment of breast cancer, and apply clinical trial data appropriately in order to optimize the outcome of individual patients.

Faculty and Staff Disclosures

Ruth O'Regan, MD
Professor of Hematology and Medical Oncology
Louisa and Rand Glenn Family Chair in Breast Cancer Research
Director, Hematology Oncology Fellowship Program
Winship Cancer Institute
Medical Director
Emory Breast Center
Chief of Hematology and Medical Oncology
Georgia Cancer Center for Excellence
Grady Hospital
Winship Cancer Institute of Emory University
Atlanta, GA

Disclosure -- Grant/Research Support: Genentech, Novartis; Consultant: Novartis.

The following individuals have no relevant financial relationships with commercial interests:
The staff of PER®, LLC (Ann C. Lichti, CCMEP, and Emily Valko Lohrmann), Kathleen Krafton, PhD (medical writer), and Stefanie Stendardo, PhD (medical reviewer).

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of PER® to ensure the fair balance, independence, objectivity, and scientific objectivity in all of our CME activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

CME Provider Contact Information

Physicians' Education Resource®, LLC
666 Plainsboro Road, Suite 356
Plainsboro, NJ 08536
Toll Free: 888-949-0045
Local: 609-378-3701
Fax: 609-257-0705

Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) ¦ Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Calendar of Events
Filter By